Devices › Catheter, intravascular, therapeutic, short-term less than 30 days
Device brand name · Peripheral iv catheters
BD Nexiva: medical device reports filed with FDA
372 reports name it, 2010–2026. Manufacturer given most often on reports: Becton Dickinson Infusion Therapy Systems. Product code FOZ.
- 372
- device reports naming the brand
- 0% of all MAUDE reports · about 23 a year
- 14
- reports, 12 months to August 2026
- 93 in the 12 months before
- 94.6%
- classified as malfunction
- 83.5% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 372 reports that name the brand "BD Nexiva" (peripheral iv catheters), received between June 2010 and August 2026; the manufacturer given most often on reports is Becton Dickinson Infusion Therapy Systems. Spellings of one product vary from report to report.
14 reports arrived in the 12 months to August 2026, down 85% from 93 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (94.6%), injury (4%) and other (1.3%); across all catheter, intravascular, therapeutic, short-term less than 30 days reports (product code FOZ) death is recorded in 0.3% and malfunction in 83.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are leak/splash (15.3%), fluid/blood leak (14.8%) and material puncture/hole (5.1%). The patient problems coded most often are hemorrhage/blood loss/bleeding, blood loss and extravasation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 49,301 reports carrying product code FOZ. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Leak/splashthe device leaked | 57 | 15.3% | 21.4% |
| Fluid/blood leak | 55 | 14.8% | 6.7% |
| Material puncture/hole | 19 | 5.1% | 2.3% |
| Breakthe device broke | 17 | 4.6% | 10.9% |
| Defective component | 15 | 4% | 2.6% |
| Material separation | 14 | 3.8% | 4.2% |
| Difficult or delayed separation | 12 | 3.2% | 0.2% |
| Separation failure | 10 | 2.7% | 0.2% |
| Device contamination with chemical or other material | 8 | 2.2% | 5.9% |
| Separation problem | 6 | 1.6% | 0.2% |
| Crackthe device cracked | 5 | 1.3% | 2.1% |
| Device misassembled during manufacturing /shipping | 5 | 1.3% | 0% |
| Detachment of device or device componentpart of the device came off | 4 | 1.1% | 1.3% |
| Difficult or delayed activation | 4 | 1.1% | 0.6% |
| Material deformation | 4 | 1.1% | 2% |
| Stretched | 4 | 1.1% | 0.3% |
| Disconnection | 3 | 0.8% | 0.7% |
| Material split, cut or torn | 3 | 0.8% | 1.5% |
| Physical resistance/sticking | 3 | 0.8% | 1% |
| Retraction problem | 3 | 0.8% | 9% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Hemorrhage/blood loss/bleeding | 5 | 1.3% |
| Blood loss | 3 | 0.8% |
| Extravasation | 3 | 0.8% |
| Swellingswelling | 3 | 0.8% |
| Abscessa collection of pus | 2 | 0.5% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 2 | 0.5% |
| Erythemaskin redness | 2 | 0.5% |
| Exposure to body fluids | 2 | 0.5% |
| Needle stick/puncture | 2 | 0.5% |
| Device embedded in tissue or plaque | 1 | 0.3% |
| Discomfortdiscomfort | 1 | 0.3% |
| Failure of implant | 1 | 0.3% |
| Foreign body embolism | 1 | 0.3% |
| Hematomaa collection of blood under the skin or in tissue | 1 | 0.3% |
| Hemolysis | 1 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | BD Nexiva | Product code FOZ | All MAUDE reports |
|---|---|---|---|
| Reports | 372 | 49,301 | 26,136,888 |
| Share of that pool | — | 0.8% | 0% |
| Classified as death, per 1,000 reports | 0 | 3 | 9 |
| Classified as injury | 4% | 13.1% | 36.2% |
| Classified as malfunction | 94.6% | 83.5% | 62.3% |
| Filed by the manufacturer | 67.7% | 89.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code FOZ
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Insyte AUTOGUARD | 1,314 | 1,050 | 0% |
| BD Insyte Autoguard | 1,246 | 55 | 0% |
| Introcan Safety | 1,255 | 45 | 0.1% |
| Bd Insyte Autog Bc | 695 | 0 | 0% |
| Arrow Cvc Set 3-Lumen 7 Fr X 20 Cm | 1,110 | 123 | 0.1% |
| Arrow Cvc Set 2-Lumen 7 Fr X 20 Cm | 1,406 | 170 | 0.1% |
| Nexiva | 385 | 304 | 0% |
| Mahurkar | 1,046 | 6 | 1.1% |
| Jelco | 363 | 34 | 0% |
| Arrow Pi Cvc Kit 3-L 7 Fr X 20 Cm Agb | 286 | 63 | 1% |
| Arrow Cvc Set 16 Ga X 8 20 Cm | 551 | 0 | 0% |
| Arrow Cvc Set 3-Lumen 7 Fr X 30 Cm | 338 | 12 | 0% |
| Bd Nexiva Single Port | 224 | 0 | 0% |
| Unspecified Bd Catheter | 251 | 0 | 0% |
| Accu-Chek Tender Infusion Set | 839 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about BD Nexiva reports
How many FDA reports name BD Nexiva?
372 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 14 in the latest 12 months.
What kinds of events are reported?
malfunction (94.6%), injury (4%) and other (1.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
leak/splash (15.3%), fluid/blood leak (14.8%), material puncture/hole (5.1%), break (4.6%) and defective component (4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (67.7%) and voluntary reports (5.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that BD Nexiva was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.